TCF11/NRF1 Antibody [F22N18]

Katalog-Nr. F0861

Drucken

Biologische Beschreibung

Spezifität TCF11/NRF1 Antibody [F22N18] detektiert endogene Spiegel des gesamten TCF11/NRF1-Proteins.
Hintergrund TCF11, auch bekannt als NRF1 (nukleärer Faktor, erythroid 2-verwandter Faktor 1), ist ein CNC-bZIP (Cap'n'collar basic leucine zipper)-Transkriptionsfaktor, der zur Nrf-Familie gehört, ubiquitär in Geweben exprimiert wird und als multiple Isoformen existiert, einschließlich einer 120 kDa ER-membrangebundenen Form und einer 65 kDa nukleär-truncaten Variante. TCF11 besitzt eine bZIP-Domäne für die DNA-Bindung an Antioxidantien-Response-Elemente (AREs), Neh1L (CNC-Domäne mit bZIP), Neh2L (ETGE/Neh2-ähnliches Degron für Keap1-Interaktion), Neh4L/Neh5L (Transaktivierungsdomänen) und Neh6L (mit Serin-reichen Motiven für GSK3-Phosphorylierung und CRL3-vermittelte Degradation), neben N-terminalen sauren Glukose-responsiven und ER-zielgerichteten Domänen, die eine topologische Repartitionierung ermöglichen. TCF11 transloziert aus dem ER in den Zellkern nach Proteasom-Inhibition über p97/VCP-abhängige Retrotranslokation und proteolytische Prozessierung, wo es mit kleinen Maf-Proteinen heterodimerisiert, um AREs zu binden und Proteasom-Untereinheitengene (z. B. PSMB5-8) transkriptionell zu induzieren, wodurch die proteolytische Kapazität wiederhergestellt und proteotoxischer Stress gemildert wird. Dieser Mechanismus reguliert auch Gene der mitochondrialen Biogenese, oxidative Stressreaktionen über GCLC und Zytoprotektion gegen Rotenon-induzierte Schäden, wobei TCF11 stärkere tumorunterdrückende Wirkungen als Nrf1α ausübt, indem es Überlebensgene im hepatozellulären Karzinom hochreguliert. Dysregulationen verbinden TCF11 mit Neurodegeneration und Krebsentwicklung aufgrund einer beeinträchtigten Redox-/Proteostase-Homöostase.

Nutzungsinformationen

Anwendung WB Verdünnung
WB
1:1000
Reaktivität Human, Mouse, Monkey
Quelle Rabbit Monoclonal Antibody MW 120-140 kDa
Lagerpuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Lagerung
(Ab dem Datum des Erhalts)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
5. Take a small amount of the lysate to determine the protein concentration;
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referenzen

  • https://pubmed.ncbi.nlm.nih.gov/34268128/
  • https://pubmed.ncbi.nlm.nih.gov/24695487/

Anwendungsdaten

WB

Validiert von Selleck

  • F0861-wb
    Lane 1: U-2 OS, Lane 2: U-2 OS (MG132, 10 µM, 8 h)